医药论文英文摘要中的常见错误与评改

要

1、医药科技工作者撰写医药论文时一般要求附英文摘要，英文摘要写得准确与 否，很大程度上体现了作者的学术水平，也与论文的影响力有很大关系。我们有幸 从《医药导报》杂志社获取了相当数量论文的英文摘要原稿。该刊特邀英文校译— —同华中科技大学同济医学院冯新为教授，年逾九旬仍伏案笔耕，为这些稿件做了 大量细致深入的校译工作，可谓句句汗水字字珠玑。给医药科技论文英文摘要的写 作提供了一个范本，对广大医药科技工作者来说也是一次极其珍贵的学习机会。本 刊特辑录刊载其原文及冯教授所作修正、点评，以飨读者。 2、编制体例：本文按照原文、修正、点评次序编写；修改、插入处以黑体斜体 ，删节处附括号说明，如有点评附上标数字注明。 1、原文： DeterminationofGallicAcidinZhixuetingLiquidsbyTLCScanning ZHOUQun1,XULa-ying2(1.DepartmentofPharmacology,TongjiMedicalC ollege,HuazhongUniversityofScienceandTechnology,Wuhan430030,Ch ina;2.TheFacultyofPharmacy,HubeiCollegeofTraditionalChineseMe dicine,Wuhan430061,China) ABSTRACTObjective:TodeterminethecontentofgallicacidinZhixueti ngliquids.Methods:Zhixuetingliquidsweredissolvedbydistilledwat er,andthenextractedintothesamplewithbutanaletc.Thesampleswe redeterminatedbyTLCscanning(λS=280nm,λR=350nm).Result:Theaver agerecoveryratewas96.36%andRSD=2.39%.Thecontentsofgallicacid in3fivebatchesofsampleswere0.38,0.42and0.47mg/ml.Conclusion: Themethodissimple,convenientandavailable. KEYWORDSTLCScanning;Zhixuetingliquids;Determination;Gallicacid 修正： DeterminationofGallicAcidinChuxueting1oralLiquidsbyTLCScannin g ZHOUQun1,XULa-ying2(1.SchoolofPharmacy2,TongjiMedicalCollege, HuazhongUniversityofScienceandTechnology,Wuhan430030,China;2. TheFacultyofPharmacy,HubeiCollegeofTraditionalChineseMedicine, Wuhan430061,China) AbstractObjective:TodeterminethecontentofgallicacidinChuxueti ngoralLiquids.Methods:TheChuxuetingoralLiquidwasdissolvedind istilledwater,andthenextracted（intothesample删去）withwater-s aturaledn-butanol3etc.forthepreparationofsamples.Thesampleswe resubjectedtogallicaciddeterminationbyTLCscanning(λS=280nm,λ R=350nm).Results:Theaveragerateofrecoverywas96.36%,（and删去） RSD=2.39%.Thecontentsofgallicacidin3（five删去）batchesofsam pleswere0.38,0.42and0.47mg/mlrespectively.Conclusion:Themethod issimple,convenientandfeasible. KEYWORDSTLCScanning;ChuxuetingoralLiquids;Determination;Gallic acid 点评： 1、zhixueting应为“止血停”而非“出血停”，自相矛盾。“出血停”也可译为 hemorrhage-stopping，以方便国外读者理解。 2、school可作“（大学里的）院”解，原意是“药学院”，而非“药理教研室” ，故改之。 3、斜体n表示“正”。2、原文：

ContentDeterminationofEmodininQingreMingmuCapsules

LUOMing-zhu1,ZHANGHong2(1.HubeiProviceInstituteofDrugControl,

Wuhan430030,China;2.The75310MedicalTeamoftheArmy)

ABSTRACTObjectives:TodeterminationcontentofEmodininQingreMingm

uCapsules.Methods:Tlcswasused,silicagelTlcplate,developingso

lventwasBenzene-Ethylfermate-formicacid-Methanol-water(3:1:0.05:0.1

:0.5)ofwhichtheuppersolutionλS=435nm,λR=530nm.Result:Thelinea

rrelationshipofsampleapplicationwhichrangedbetween0.168-3.09μg

wasgood.Theregressionequationwasbelow:Y=105417.7X-1115.6,r=0.9

995;areragerecoverywas100.53%,RSD=3.38%.Conclusion:Thismethodi

ssimple,accurateandconvenient.

KEYWORDSTLcs;QingremingmuCcapsules;Emodin

修正：

DeterminationofEmodinContentinQingremingmu1Capsules

LUOMing-zhu1,ZHANGHong2(1.HubeiProvicialInstituteofDrugControl

,Wuhan430030,China;2.The75310MedicalTeamoftheArmy)

ABSTRACTObjective:Tosetupamethodforthedetermination（content删

去）ofEmodincontentinQingreMingmuCapsules.Methods:IntheTLCa

ssay,a0.5%canboxymethylcellulosesodium(wasused删去)silicagelG

plateandadevelopingsolventwithamixtureofbenzene—ethylformat

e—formicacid—methanol—water(3:1:0.05:0.1:0.5)astheuppersolution

wereused.λS=435nm,λR=530nm.Results:Agoodlinearrelationshipwas

foundwhenthesampleamount(which删去)rangedbetween0.168-3.09μg

（wasgood删去）.Theregressionequationwasasfollows:Y=105417.7X-1

115.6,r=0.9995.Theaveragerateofrecoverywas100.53%,RSD=3.38%.Co

nclusion:Themethodissimple,convenientandaccurate.

KEYWORDSTLC;QingreMingmuCcapsules;Emodin

点评：

1、中成药名用斜体书写，也可译作removingpathogenicheattoimproveacui

tyofvision。



3、原文：

ResearchonTheAcuteToxicityofHuningCapsule

XINZhi-wei,ZANGZhi-he,MAIXiao-xia,FENGJun,YANGWan-qing,LIAOH

ong-li(TeachingandResearchSectionofPharmacy,TheThirdMedicalUn

iversity,ChengduCollegeofPLA610081,China)

ABSTRACTObjective:ToobserveandtesttheacutetoxicityofHuningCa

psuleonKunmingmiceafterani.g.Methods:Countthedeathcasesofm

icein7daysafterthei.g.andworkouttheLD50ofHuningCapsule.R

esults:TheLD50ofHuningCapsuleonmiceis3981mg/kg.

KEYWORDSHuningCapsule;AcuteToxicity;LD50

修正：

AnExperimentalStudyoftheAcuteToxicityofHuningCapsules1

XINZhi-wei,ZANGZhi-he,MAIXiao-xia,FENGJun,YANGWan-qing,LIAOH

ong-li(TeachingandResearchSectionofPharmacy,ChengduMilitaryMed

icalCollege,TheThirdMilitaryMedicalUniversity,Chengdu610081,Ch

ina)

ABSTRACTObjective:ToobserveanddeterminetheacutetoxicityofHuni

ngcapsules(onKunmingmice删去)afterasingleintragastricadministr

ationinthemouse.Methods:50Kunmingmicewererandomlydividedinto

5equalgroups,with10animalsineachgroup.Asingledoseof7500,

5630,4200,3150and2360mg/kg-1ofthecontentofthecapsulesweread

ministenedthroughagastrictubetoeachofthemiceofthe5groups,

respectively.Thenumbersofthedeathsofthemicewithin7dayswere

noteddownandthemediarletherdose(LD50)ofHuningCapsuleswascal

culated.(Countthedeathcasesofmicein7daysafterthei.g.andwo

rkouttheLD50ofHuningCapsule.删去)Results:TheLD50ofHuningCa

psuleinmicewas3981mg/kg.Conclusion:HuningCapsuleshaveonlyami

noracutetoxicity.Itisthereforesafetousethedrugclinically.Fu

rtherstudyofitstoxicityinlong-termapplicationisrequired.

KEYWORDSHuningCapsules;Toxicity,acute;LD50